Every Form 4 that NANO-X IMAGING LTD (NNOX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NNOX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NNOX filings page.
Nano-X Imaging Ltd. (NNOX) CEO and director Erez Meltzer indirectly purchased 25,000 ordinary shares on October 19, 2026, at $0.45 per share through Oud Nof, a company wholly owned by him. Oud Nof held 90,443 shares after the purchase. No Rule 10b5-1 plan is reported. The report separately lists 60,584 ordinary shares held directly as of October 19, 2026, and three direct option positions.
Nano-X Imaging Ltd. granted Chief Corporate Resources Attias Gali Yahav 28,283 ordinary shares represented by restricted share units on October 14, 2026, under its 2019 Equity Incentive Plan. The units vest in four equal semi-annual installments of 25% each on February 13, 2027, August 13, 2027, February 13, 2028, and August 13, 2028, subject to his continuous employment on each vesting date. As of October 14, 2026, he also held directly options for 6,500 ordinary shares at an exercise price of $23.86, expiring September 30, 2031; 12,500 ordinary shares at $17.63, expiring March 28, 2032; and 40,000 ordinary shares at $11.52, expiring May 23, 2033. The 6,500-share and 12,500-share options were fully vested and exercisable.
Nano-X Imaging Ltd.’s board granted its General Manager AI Division, Sharon Saban, 28,283 ordinary shares represented by restricted share units (RSUs) on October 14, 2026, under the 2019 Equity Incentive Plan. The RSUs vest and settle in four equal semiannual installments of 25% following an August 13, 2026 vesting commencement date, subject to Saban’s continuous employment on each applicable date; all underlying shares are to be issued by August 13, 2028. A separate RSU holding from a February 5, 2026 grant is scheduled to vest 50% on February 5, 2027, and 50% on February 5, 2028. Saban also held 15,000 fully vested and exercisable options to buy ordinary shares at $17.63 each, expiring September 15, 2032.
Nano-X Imaging Ltd. reported that its board granted CFO Guy Nathansohn 50,000 restricted share units (RSUs) representing 50,000 ordinary shares on October 14, 2026. The award is scheduled to vest and settle in two 25,000-unit installments on October 14, 2027 and October 14, 2028, subject in each case to his continuous employment on the applicable vesting date. A separate informational holding entry lists 50,000 RSUs granted July 15, 2026, with 25,000-unit installments scheduled for July 15, 2027 and July 15, 2028, subject to the same employment condition.
Nano-X Imaging Ltd. granted Chief Legal Officer Feler Marina Gofman 28,283 restricted share units on October 13, 2026, under its 2019 Equity Incentive Plan. The units vest and settle for ordinary shares in four equal semi-annual installments of 25% each, on February 13, 2027, August 13, 2027, February 13, 2028, and August 13, 2028, subject in each case to her continuous employment. Separate informational holdings list direct options covering 15,000, 10,000, and 30,000 ordinary shares.
Nano-X Imaging Ltd. officer Dara James, whose title is GM Source & Services Division, received a grant of 28,283 restricted share units (RSUs) on October 11, 2026, under the 2019 Equity Incentive Plan. The RSUs vest and settle for ordinary shares in four equal semi-annual installments of 25% on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject in each case to Dara James’s continued employment by Nano-X Imaging Ltd.
Nano-X Imaging Ltd. General Manager, ARC Division Ofir Koren received a grant of 28,283 ordinary shares represented by RSUs on October 10, 2026, under the 2019 Equity Incentive Plan. The RSUs vest in four equal semi-annual installments beginning February 13, 2027, subject to continuous employment on each vesting date. Koren also reported direct options covering 100,000 ordinary shares at a $49.68 exercise price, 25,000 at $17.63, and 33,500 at $11.52; the first two option tranches are fully vested and exercisable.
Nano-X Imaging Ltd. (NNOX) EVP & Chief Marketing Officer Cohen Tamar Aharon was granted 28,283 restricted share units on October 11, 2026. They vest in four equal semi-annual installments of 25% each on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject to continuous employment on each vesting date. Separate informational holdings list direct options over 33,000, 17,000, 8,000 and 55,000 ordinary shares, with exercise prices of $49.68, $17.63, $17.63 and $11.52, respectively.
Nano-X Imaging Ltd. (NNOX) reports that Chief Executive Officer and director Erez Meltzer, through a wholly owned company, purchased 10,000 ordinary shares of the company on September 15, 2026 at $0.69 per share, increasing his indirectly held position to 65,443 shares. He also directly holds 60,584 ordinary shares and maintains stock options over 490,234 underlying shares at exercise prices between $2.21 and $23.84, with expirations from 2030 to 2034, some of which vest over time through April 16, 2028. No Rule 10b5-1 trading plan is reported.
Nano-X Imaging Ltd. (NNOX) director Dan S. Suesskind reported open-market purchases of a total of 60,000 Ordinary Shares on September 14, 2026, in two trades of 30,000 shares at $0.76 and 30,000 shares at $0.75 per share. No Rule 10b5-1 trading plan is reported. He also continues to hold vested and unvested stock options covering 72,505 Ordinary Shares with exercise prices between $11.52 and $64.61 and expirations from 2031 to 2033, plus RSU-based Ordinary Share holdings that vest in quarterly installments through 2028.
Nano-X Imaging Ltd. (NNOX) reported that Chief Executive Officer and director Erez Meltzer, through his wholly owned company Oud Nof, purchased 10,000 ordinary shares on September 10, 2026 at $0.78 per share, increasing his indirect holdings to 55,443 shares. He also holds 60,584 ordinary shares directly and stock options over 40,234 shares at $2.21 (expiring February 11, 2030), 300,000 shares at $23.84 (expiring January 2, 2032), and 150,000 shares at $11.52 (expiring April 16, 2034). The 2024 option grant vests 25% after one year and 6.25% quarterly over the following three years, becoming fully vested on April 16, 2028. No Rule 10b5-1 trading plan is reported.
Nano-X Imaging Ltd. director and Chief Executive Officer Erez Meltzer reported purchasing 9,443 Ordinary Shares on August 10, 2026 at $1.03 per share. The shares were bought indirectly through Oud Nof, a company wholly owned by him, bringing that entity’s holdings to 45,443 Ordinary Shares. He also reports direct ownership of 60,584 Ordinary Shares, and three existing stock option grants over 40,234, 300,000, and 150,000 underlying Ordinary Shares at exercise prices of $2.21, $23.84, and $11.52, expiring in 2030, 2032, and 2034, respectively. The later option grant from April 16, 2024 vests over four years and is scheduled to be fully vested by April 16, 2028.
Nano-X Imaging Ltd. director Suesskind Dan S reported open-market purchases of a total of 50,000 Ordinary Shares on July 27, 2026, in two blocks of 25,000 shares at $0.94 and $0.92 per share. The Rule 10b5-1 checkbox was not marked for these transactions.
He also reports outstanding stock options to acquire 12,505 shares at $64.6100, 50,000 shares at $17.6300, and 10,000 shares at $11.5200, with expirations between 2031 and 2033, plus time-vested RSUs granted in 2024 and 2025.
Nano-X Imaging Ltd. director Kainan Noga purchased 33,000 ordinary shares on July 28, 2026 at $0.9000 per share in an open-market or private transaction. He also reports existing stock options over 12,505, 50,000 and 10,000 shares at exercise prices of $64.6100, $17.6300 and $11.5200, plus 794 ordinary shares held indirectly through I.B.L. Business Consulting Ltd. Additional ordinary shares are reported as underlying restricted share units granted December 10, 2025 that vest in twelve equal monthly installments.
Nano-X Imaging Ltd. CFO Daniel Ran reported a disposition of 1,000 Ordinary Shares back to the issuer on 2026-07-29 at $0.89 per share. After this issuer-related transaction, Ran directly holds 5,950 Ordinary Shares. The transaction is classified as a disposition to the issuer and was not marked as made under a Rule 10b5-1 trading plan.
Nano-X Imaging Chief Executive Officer Erez Meltzer, through his wholly owned company Oud Nof, purchased 36,000 ordinary shares on July 27, 2026 at $0.93 per share, reported as indirect ownership. The report also lists existing direct holdings of 60,584 shares and several vested and vesting stock option grants with exercise prices between $2.21 and $23.84, expiring from 2030 to 2034.
Nano-X Imaging Ltd. director Alroy Erez sold 678 ordinary shares on June 10, 2026 at $1.65 per share in open-market transactions. A footnote explains that the reported sale of ordinary shares was used to cover tax liabilities arising from the vesting of restricted share units.
Following these transactions, Erez continues to hold ordinary shares tied to RSU grants, including 6,753 and 17,075 ordinary shares remaining or issuable under two separate awards. He also holds stock options over 10,000 ordinary shares at an exercise price of $11.52 expiring on December 31, 2033, and options over 50,000 ordinary shares at an exercise price of $17.63 expiring on December 28, 2032.
Nano-X Imaging Ltd. CFO Daniel Ran reported a disposition of ordinary shares back to the company. On March 18, 2026, he transferred 39,474 ordinary shares to the issuer at a stated price of $0.00 per share. After this issuer-related disposition, he directly holds 46,424 ordinary shares, according to the filing.